Skip to content
drillr
.ai
Product
▼
Datasets
▼
Docs
(opens in a new tab)
Pricing
Ideas
Benchmark
Sign in
Sign up
N
NCEL
NewCelX Ltd.
NASDAQ
Healthcare
Biotechnology
CH
NASDAQ · Healthcare · Biotechnology · CH
Also listed · NCEL.CH →
$2.49
−5.87%
+ Watch
Ask drillr
Overview
Financials
Valuation
Profitability
Growth
Capital
Momentum
Earnings
Ownership
News
Ideas
Jul 31, 2026, 13:00 UTC
NewcelX priced a $1.4 million private equity financing at a 20% premium to support its lead Type 1 Diabetes program.
Source:
globenewswire.com
